BBLG   $1.01  -8.18% Market Closed

Bone Biologics Corp
Total Cash 2.33M
totalCashPerShare 1.295
EBITDA
Total Debt 0.00
quickRatio 8.197
currentRatio 11.225
Total Revenue
debtToEquity
Revenue/Share
ROA -0.57252
ROE -1.19029
grossProfits
freeCashflow -4.83M
operatingCashflow -6.77M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 9.79K
forwardPE -0.59360725
floatShares 1.72M
sharesOutstanding 2.10M
sharesShort 48.58K
sharesShortPriorMonth 28.65K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.05%
heldPercentInstitutions 0.03%
Short Ratio help_outline 0.01%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 2.211
Price To Book help_outline 0.59
earningsQuarterlyGrowth
netIncomeToCommon -5.12M
trailingEps -15.88%
forwardEps -2.19%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.6 3Q 2024
institutionsCount 7
lastUpdated Nov. 7, 2024, 6:56 a.m.